Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
sNN0031 in Parkinson's Disease
NCT00866502Phase 2Completed
- Sponsor
- Newron Pharmaceuticals
- Start
- Mar 2009
- Primary completion
- Mar 2011
- Modality
- Hormones & Growth Factors
- Countries
- 1
01
Overview
A Phase 2 trial of sNN0031 in Parkinson's disease (PD), sponsored by Newron Pharmaceuticals. Started Mar 2009; status: completed.
02
Drugs
sNN0031
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00866502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00866502.